3-Pyridin-3-yl-2H-1,2,4-oxadiazol-5-one, 97%, 250mg

6'-(Indolin-1-yl)-1,3,3-trimethylspiro[indoline-2,3'-naphtho[2,1-b][1,4]oxazine], 95%, 25g

(S)-2-((tert-Butoxycarbonyl)amino)-3-(trityloxy)propanoic acid, 95+%, 250g

Methyl 3-(trimethylsilyl)pent-4-enoate, 95.0%, 10g

2,4,6-Tris(3-bromophenyl)-1,3,5-triazine>98.0%(HPLC)(N)5g

4-(2-Bromophenyl)butan-1-amine, 98%, 1g

Methyl 4-chloro-8-methoxyquinoline-2-carboxylate, 97%, 250mg

6-Methoxy-5-nitropicolinic acid, 95.0%, 1g

(3aR,4S,5R,6aS)-5-Hydroxy-4-(hydroxymethyl)hexahydro-2H-cyclopenta[b]furan-2-one, 95.0%, 25g

2-Butylfuran, 98%, 25g

Thieno[2,3-c]pyridine-5-carboxylic acid, 95.0%, 2g

Diethyl 2-(2-cyanoethyl)malonate, 95.0%, 100g

Dextran 500, for biochemistry, 500 g, plastic packaging.